170 related articles for article (PubMed ID: 2947669)
1. Dementia in movement disorders.
Teräväinen H; Hietanen M; Stoessl J; Calne DB
Can J Neurol Sci; 1986 Nov; 13(4 Suppl):546-58. PubMed ID: 2947669
[TBL] [Abstract][Full Text] [Related]
2. Subcortical dementia. Review of an emerging concept.
Cummings JL; Benson DF
Arch Neurol; 1984 Aug; 41(8):874-9. PubMed ID: 6235797
[TBL] [Abstract][Full Text] [Related]
3. The scintigraphic evaluation of Huntington's disease and other movement disorders using single photon emission computed tomography perfusion brain scans.
Nagel JS; Ichise M; Holman BL
Semin Nucl Med; 1991 Jan; 21(1):11-23. PubMed ID: 1825359
[TBL] [Abstract][Full Text] [Related]
4. Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy.
Pillon B; Dubois B; Agid Y
Ann N Y Acad Sci; 1991; 640():224-7. PubMed ID: 1837977
[TBL] [Abstract][Full Text] [Related]
5. Differential diagnosis of Alzheimer's disease.
Geldmacher DS; Whitehouse PJ
Neurology; 1997 May; 48(5 Suppl 6):S2-9. PubMed ID: 9153154
[TBL] [Abstract][Full Text] [Related]
6. The co-occurrence of Alzheimer's disease and Huntington's disease: a neuropathological study of 15 elderly Huntington's disease subjects.
Davis MY; Keene CD; Jayadev S; Bird T
J Huntingtons Dis; 2014; 3(2):209-17. PubMed ID: 25062863
[TBL] [Abstract][Full Text] [Related]
7. Topographic investigation of brain atrophy in parkinsonism-dementia complex of Guam: a comparison with Alzheimer's disease and progressive supranuclear palsy.
Oyanagi K; Makifuchi T; Ohtoh T; Ikuta F; Chen KM; Chase TN; Gajdusek DC
Neurodegeneration; 1994 Dec; 3(4):301-4. PubMed ID: 7842300
[TBL] [Abstract][Full Text] [Related]
8. Apraxia in movement disorders.
Zadikoff C; Lang AE
Brain; 2005 Jul; 128(Pt 7):1480-97. PubMed ID: 15930045
[TBL] [Abstract][Full Text] [Related]
9. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease.
Aarsland D; Litvan I; Salmon D; Galasko D; Wentzel-Larsen T; Larsen JP
J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1215-20. PubMed ID: 12933921
[TBL] [Abstract][Full Text] [Related]
10. Comparison of cathepsin protease activities in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease.
Mantle D; Falkous G; Ishiura S; Perry RH; Perry EK
J Neurol Sci; 1995 Jul; 131(1):65-70. PubMed ID: 7561949
[TBL] [Abstract][Full Text] [Related]
11. Dementia of the Alzheimer's type and Huntington's disease.
Reyes MG; Gibbons S
Neurology; 1985 Feb; 35(2):273-7. PubMed ID: 3155827
[TBL] [Abstract][Full Text] [Related]
12. Nicotinic and muscarinic cholinergic receptors in Alzheimer's disease and related disorders.
Whitehouse PJ; Kellar KJ
J Neural Transm Suppl; 1987; 24():175-82. PubMed ID: 2960781
[TBL] [Abstract][Full Text] [Related]
13. Pathological overlap in cases of parkinsonism associated with neurofibrillary tangles. A study of recent cases of postencephalitic parkinsonism and comparison with progressive supranuclear palsy and Guamanian parkinsonism-dementia complex.
Geddes JF; Hughes AJ; Lees AJ; Daniel SE
Brain; 1993 Feb; 116 ( Pt 1)():281-302. PubMed ID: 8453463
[TBL] [Abstract][Full Text] [Related]
14. The morphological basis of dementia in Parkinson's disease.
Ball MJ
Can J Neurol Sci; 1984 Feb; 11(1 Suppl):180-4. PubMed ID: 6713315
[TBL] [Abstract][Full Text] [Related]
15. The neostriatum and nucleus accumbens in parkinsonism-dementia complex of Guam: a pathological comparison with Alzheimer's disease and progressive supranuclear palsy.
Oyanagi K; Makifuchi T; Ohtoh T; Chen KM; Gajdusek DC; Chase TN; Ikuta F
Acta Neuropathol; 1994; 88(2):122-8. PubMed ID: 7985492
[TBL] [Abstract][Full Text] [Related]
16. Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy.
Pillon B; Dubois B; Ploska A; Agid Y
Neurology; 1991 May; 41(5):634-43. PubMed ID: 1827513
[TBL] [Abstract][Full Text] [Related]
17. The nucleus basalis of Meynert.
Ezrin-Waters C; Resch L
Can J Neurol Sci; 1986 Feb; 13(1):8-14. PubMed ID: 2937514
[TBL] [Abstract][Full Text] [Related]
18. Is "subcortical dementia" a recognizable clinical entity?
Mayeux R; Stern Y; Rosen J; Benson F
Ann Neurol; 1983 Sep; 14(3):278-83. PubMed ID: 6227275
[TBL] [Abstract][Full Text] [Related]
19. Chapter 33: the history of movement disorders.
Lanska DJ
Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomographic (PET) studies in dementia.
Goto I; Taniwaki T; Hosokawa S; Otsuka M; Ichiya Y; Ichimiya A
J Neurol Sci; 1993 Jan; 114(1):1-6. PubMed ID: 8433091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
